Why is primary prophylaxis underutilized in the United States?

被引：13

作者：

Shapiro, AD ^{[1
]}

机构：

[1] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN 46260 USA

来源：

HAEMOPHILIA | 2003年 / 9卷 / 06期

关键词：

catheters; demography; factor VIII; haemophilia A; haemorrhage; in dwelling; prophylaxis;

D O I：

10.1046/j.1351-8216.2003.00833.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A recent article published in Haemophilia reports the results of a survey of treatment center practices in the United States, and specifically the use of prophylaxis as treatment regimen [7] . This article discusses the issues that may contribute to utilization of prophylactic regimens and issues to consider when determining treatment programs for pediatric patients.

引用

页码：670 / 672

页数：3

共 10 条

[1] Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized [J].

Astermark, J ;

Petrini, P ;

Tengborn, L ;

Schulman, S ;

Ljung, R ;

Berntorp, E .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) :1109-1113

[2]

Berntorp E, 1995, B WORLD HEALTH ORGAN, V73, P691

[3] Consensus perspectives on prophylactic therapy for haemophilia:: summary statement [J].

Berntorp, E ;

Astermark, J ;

Björkman, S ;

Blanchette, VS ;

Fischer, K ;

Giangrande, PLF ;

Gringeri, A ;

Ljung, RC ;

Manco-Johnson, MJ ;

Morfini, M ;

Kilcoyne, RF ;

Petrini, P ;

Rodriguez-Merchan, EC ;

Schramm, W ;

Shapiro, A ;

Van Den Berg, HM ;

Hart, C .

HAEMOPHILIA, 2003, 9 :1-4

[4] A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres [J].

Blanchette, VS ;

McCready, M ;

Achonu, C ;

Abdolell, M ;

Rivard, G ;

Manco-Johnson, MJ .

HAEMOPHILIA, 2003, 9 :19-26

[5] Practice patterns in haemophilia A therapy - a survey of treatment centres in the United States [J].

Butler, RB ;

McClure, W ;

Wulff, K .

HAEMOPHILIA, 2003, 9 (05) :549-554

[6] The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia [J].

Fischer, K ;

van der Bom, JG ;

Mauser-Bunschoten, EP ;

Roosendaal, G ;

Prejs, R ;

de Kleijn, P ;

Grobbee, DE ;

van den Berg, M .

BLOOD, 2002, 99 (07) :2337-2341

[7] Barriers to compliance with prophylaxis therapy in haemophilia [J].

Hacker, MR ;

Geraghty, S ;

Manco-Johnson, M .

HAEMOPHILIA, 2001, 7 (04) :392-396

[8] North American prophylaxis studies for persons with severe haemophilia: background, rationale and design [J].

Manco-Johnson, MJ ;

Blanchette, VS .

HAEMOPHILIA, 2003, 9 :44-48

[9]

*NAT HEM FDN, 2001, 117 MASAC NAT HEM FD

[10] Defining the impact of hemophilia: The Academic Achievement in Children with Hemophilia study [J].

Shapiro, AD ;

Donfield, SM ;

Lynn, HS ;

Cool, VA ;

Stehbens, JA ;

Hunsberger, SL ;

Tonetta, S ;

Gomperts, ED .

PEDIATRICS, 2001, 108 (06) :E105

← 1 →